Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 12.95B | 13.67B | 8.96B | 19.93B | 27.01B | 4.39B |
Gross Profit | 4.30B | 4.49B | 3.00B | 6.87B | 10.50B | 1.11B |
EBITDA | 841.96M | -433.03M | -312.26M | 3.19B | 6.81B | -1.45B |
Net Income | 276.59M | -764.99M | -269.44M | 2.07B | 4.64B | -1.11B |
Balance Sheet | ||||||
Total Assets | 12.98B | 13.04B | 12.15B | 14.65B | 15.72B | 8.44B |
Cash, Cash Equivalents and Short-Term Investments | 5.14B | 6.79B | 6.44B | 8.09B | 7.72B | 1.37B |
Total Debt | 850.00M | 564.62M | 574.79M | 587.29M | 615.90M | 1.96B |
Total Liabilities | 2.58B | 3.88B | 2.13B | 3.85B | 6.45B | 3.89B |
Stockholders Equity | 10.40B | 9.15B | 10.03B | 10.80B | 9.26B | 4.55B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 492.70M | -1.12B | 961.82M | 7.76B | -2.36B |
Operating Cash Flow | 0.00 | 505.80M | -1.08B | 1.05B | 7.77B | -2.34B |
Investing Cash Flow | 0.00 | -13.29M | -27.34M | -82.63M | -11.58M | 44.07M |
Financing Cash Flow | 0.00 | -136.08M | -545.00M | -595.15M | -1.41B | 944.54M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥8.18B | 11.58 | 5.52% | -2.37% | -40.20% | ||
80 Outperform | ¥4.63B | 13.57 | 5.06% | 3.50% | 190.77% | ||
75 Outperform | ¥8.14B | 7.84 | 3.95% | 5.82% | 14.22% | ||
73 Outperform | ¥3.07B | 18.77 | 2.65% | 10.70% | -15.05% | ||
61 Neutral | $41.26B | -0.79 | -14.19% | 3.78% | 2.39% | -73.52% | |
57 Neutral | ¥6.27B | 73.82 | 3.24% | 11.85% | -80.65% | ||
51 Neutral | ¥5.98B | 21.77 | 2.23% | 52.55% | -187.25% |